Bye-bye urinary gonadotrophins? The use of urinary gonadotrophins should be discouraged

Human Reproduction

Volumn 17, Issue 7, 2002, Pages 1675-

  Matorras, Roberto ^a,b   Rodríguez Escudero, Francisco J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Maria Diaz de Haro   (Spain)

Author keywords

BSE; New variant CJD; TSE; Urinary gonadotrophins

Indexed keywords

GONADOTROPIN; PRION PROTEIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; RECOMBINANT PROTEIN;

BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG COST; DRUG URINE LEVEL; DRUG USE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; NONHUMAN; PRION DISEASE; PROTEIN URINE LEVEL; SHORT SURVEY; ARTICLE; CHEMISTRY; ISOLATION AND PURIFICATION; PRION; URINE;

BOVINAE;

GONADOTROPINS; HUMANS; PRIONS; RECOMBINANT PROTEINS; URINE;

EID: 0036069474     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.7.1675     Document Type: Short Survey

References (7)

1. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective
2. Transmissible spongiform encephalopathies in humans
3. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction
4. The shifting biology of prions
5. The role of LH in ovarian stimulation: Exogenous LH: Let's design the future
6. Recombinant human FSH versus highly purified urinary FSH: A randomized study in intrauterine insemination with husbands' spermatozoa
7. A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases